Home LiteratureArticle Details
PMID: 9784491 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development.

Genes & development ·Vol. 12 ·No. 20 ·1998-10-15 ·Pages 3162-7

Zhang P, Wong C, DePinho RA, Harper JW, Elledge SJ

Abstract

Cell cycle exit is required for terminal differentiation of many cell types. The retinoblastoma protein Rb has been implicated both in cell cycle exit and differentiation in several tissues. Rb is negatively regulated by cyclin-dependent kinases (Cdks). The main effectors that down-regulate Cdk activity to activate Rb are not known in the lens or other tissues. In this study, using multiple mutant mice, we show that the Cdk inhibitors p27(KIP1) and p57(KIP2) function redundantly to control cell cycle exit and differentiation of lens fiber cells and placental trophoblasts. These studies demonstrate that p27(KIP1) and p57(KIP2) are critical terminal effectors of signal transduction pathways that control cell differentiation.

MeSH Terms
Animals Cell Cycle Cell Cycle Proteins Cell Differentiation Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinase Inhibitor p57 Cyclin-Dependent Kinases/antagonists & inhibitors Embryo, Mammalian Enzyme Inhibitors/pharmacology Lens, Crystalline/cytology,embryology Mice Mice, Inbred C57BL Mice, Inbred Strains Mice, Knockout Microtubule-Associated Proteins/physiology Nuclear Proteins/physiology Placenta/cytology,embryology Tumor Suppressor Proteins
Chemicals
Cdkn1b protein, mouse Cdkn1c protein, mouse Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p57 Enzyme Inhibitors Microtubule-Associated Proteins Nuclear Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Zhang P
Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York 10461 USA.
Wong C
DePinho R A
Harper J W
Elledge S J
References (35)
35 references, click to expand
  1. Induction of the eye lens.
    Differentiation. 1980;17(3):137-49 PMID: 7004973
  2. Lens differentiation in vertebrates. A review of cellular and molecular features.
    Differentiation. 1981;19(3):134-53 PMID: 7030840
  3. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
    Cell. 1993 Feb 12;72(3):309-24 PMID: 8381715
  4. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.
    Cell. 1994 Jul 15;78(1):161-72 PMID: 8033208
  5. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators.
    Mol Cell Biol. 1994 Aug;14(8):5259-67 PMID: 8035804
  6. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.
    Nature. 1994 Sep 1;371(6492):72-4 PMID: 8072529
  7. Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
    Genes Dev. 1994 Aug 1;8(15):1772-86 PMID: 7958856
  8. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
    Mol Cell Biol. 1994 Dec;14(12):8166-73 PMID: 7969153
  9. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10918-22 PMID: 7971984
  10. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Science. 1995 Feb 17;267(5200):1018-21 PMID: 7863327
  11. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
    Science. 1995 Feb 17;267(5200):1022-4 PMID: 7863328
  12. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
    Science. 1995 Feb 17;267(5200):1024-7 PMID: 7863329
  13. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.
    J Virol. 1995 Apr;69(4):2491-500 PMID: 7884898
  14. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Genes Dev. 1995 Mar 15;9(6):650-62 PMID: 7729684
  15. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation.
    Mol Cell Biol. 1995 Jul;15(7):3823-9 PMID: 7791789
  16. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
    Cell. 1995 Aug 25;82(4):675-84 PMID: 7664346
  17. Regulation of cyclin and cyclin-dependent kinase gene expression during lens differentiation requires the retinoblastoma protein.
    Oncogene. 1996 Jan 4;12(1):69-75 PMID: 8552401
  18. Lens complementation system for the genetic analysis of growth, differentiation, and apoptosis in vivo.
    Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1303-7 PMID: 8577759
  19. Role of the INK4a locus in tumor suppression and cell mortality.
    Cell. 1996 Apr 5;85(1):27-37 PMID: 8620534
  20. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  21. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  22. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  23. Cdk inhibitors in development and cancer.
    Curr Opin Genet Dev. 1996 Feb;6(1):56-64 PMID: 8791491
  24. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.
    Mol Cell Biol. 1996 Dec;16(12):7043-53 PMID: 8943359
  25. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs.
    Genes Dev. 1996 Nov 1;10(21):2794-804 PMID: 8946919
  26. Rb functions to inhibit apoptosis during myocyte differentiation.
    Cancer Res. 1997 Feb 1;57(3):351-4 PMID: 9012453
  27. Retinoblastoma protein in growth suppression and death protection.
    Curr Opin Genet Dev. 1997 Feb;7(1):39-45 PMID: 9024632
  28. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
    Genes Dev. 1997 Apr 15;11(8):973-83 PMID: 9136926
  29. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.
    Nat Genet. 1997 May;16(1):19-27 PMID: 9140391
  30. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.
    Nature. 1997 May 8;387(6629):151-8 PMID: 9144284
  31. Distinct roles for E2F proteins in cell growth control and apoptosis.
    Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7245-50 PMID: 9207076
  32. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
    Genes Dev. 1998 Jan 1;12(1):95-106 PMID: 9420334
  33. Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice.
    Genes Dev. 1998 Mar 15;12(6):776-81 PMID: 9512512
  34. Rb binds c-Jun and activates transcription.
    EMBO J. 1998 Apr 15;17(8):2342-52 PMID: 9545246
  35. The retinoblastoma gene family: cousins with overlapping interests.
    Trends Genet. 1998 Jun;14(6):223-9 PMID: 9635405
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
0890-9369
Published
1998-10-15
Pages
3162-7
Language
English
Region
United States
NLM ID
8711660
PMCID
PMC317217
Subset
IM
Grants
NEI NIH HHS · EY09300 · United States
NEI NIH HHS · EY11267 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]